Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Availability issues for approved drugs. Case study: Nabiximols
By Harriet Doig MS Ireland includes the availability and reimbursement of MS drugs among its priorities as a patient organisation….
Providing modern MS rehabilitation
By SPEM The Portuguese MS Society (SPEM) plans to relocate, expand and modernise the only rehabilitation centre in the country…
No crutches, no benefits: The disability assessment battle
By Alina Verbnîi There are many battles facing people living with multiple sclerosis. In the Republic of Moldova, one of…
Providing modern MS rehabilitation
By SPEM The Portuguese MS Society (SPEM) plans to relocate, expand and modernise the only rehabilitation centre in the country…
No crutches, no benefits: The disability assessment battle
By Alina Verbnîi There are many battles facing people living with multiple sclerosis. In the Republic of Moldova, one of…
MS physical activity platform launched online
By Sandra Fernández The patient organisation Multiple Sclerosis Spain (EME) moved its popular Platform for Promotion of Physical Activity…
